Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,344,874
Closed -$95.9M 3
2023
Q2
$95.9M Sell
2,344,874
-1,965,639
-46% -$77M 7.92% 3
2023
Q1
$177M Sell
4,310,513
-254,120
-6% -$10.1M 14.02% 2
2022
Q4
$154M Hold
4,564,633
13.06% 2
2022
Q3
$138M Hold
4,564,633
10.57% 3
2022
Q2
$183M Buy
4,564,633
+420,000
+10% +$19.8M 12.94% 2
2022
Q1
$199M Buy
4,144,633
+875,904
+27% +$45.2M 13.77% 2
2021
Q4
$183M Buy
+3,268,729
New +$179M 15.18% 3

Other funds holding AVNT

Marquard & Bahls's AVNT Position: Q3 2023 in Review

Marquard & Bahls sold out of Avient (AVNT) in Q3 2023, closing a stake of 2,344,874 shares — an estimated $95.9M sold.

Marquard & Bahls first reported a position in AVNT in Q4 2021 and held it in 7 quarters. The position peaked at $199M in Q1 2022. 263 funds tracked by Wall St. Rank hold AVNT as of Q3 2023.

  • Marquard & Bahls reported no remaining Avient position as of Q3 2023 after selling out during the quarter.
  • Marquard & Bahls sold 2,344,874 Avient shares in Q3 2023, an estimated $95.9M.
  • Marquard & Bahls first reported a position in Avient in Q4 2021 and held it in 7 quarters.
  • Marquard & Bahls's Avient position peaked at $199M in Q1 2022.
  • 263 funds tracked by Wall St. Rank held Avient as of Q3 2023.

Based on Marquard & Bahls's 13F filing for Q3 2023, filed 9 Nov 2023.